| Product Code: ETC13351271 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Spinal Devices and Biologics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Spinal Devices and Biologics Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Spinal Devices and Biologics Market Revenues & Volume, 2021 & 2031F |
3.3 North America Spinal Devices and Biologics Market - Industry Life Cycle |
3.4 North America Spinal Devices and Biologics Market - Porter's Five Forces |
3.5 North America Spinal Devices and Biologics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Spinal Devices and Biologics Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.7 North America Spinal Devices and Biologics Market Revenues & Volume Share, By Biologics Type, 2021 & 2031F |
3.8 North America Spinal Devices and Biologics Market Revenues & Volume Share, By Surgery Type, 2021 & 2031F |
3.9 North America Spinal Devices and Biologics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 North America Spinal Devices and Biologics Market Revenues & Volume Share, By Product Form, 2021 & 2031F |
4 North America Spinal Devices and Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Spinal Devices and Biologics Market Trends |
6 North America Spinal Devices and Biologics Market, 2021 - 2031 |
6.1 North America Spinal Devices and Biologics Market, Revenues & Volume, By Device Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Spinal Devices and Biologics Market, Revenues & Volume, By Spinal Implants, 2021 - 2031 |
6.1.3 North America Spinal Devices and Biologics Market, Revenues & Volume, By Spinal Biologics, 2021 - 2031 |
6.1.4 North America Spinal Devices and Biologics Market, Revenues & Volume, By Spinal Rods, 2021 - 2031 |
6.1.5 North America Spinal Devices and Biologics Market, Revenues & Volume, By Spinal Cages, 2020 - 2028 |
6.2 North America Spinal Devices and Biologics Market, Revenues & Volume, By Biologics Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Spinal Devices and Biologics Market, Revenues & Volume, By Bone Grafts, 2021 - 2031 |
6.2.3 North America Spinal Devices and Biologics Market, Revenues & Volume, By Stem Cell Therapy, 2021 - 2031 |
6.2.4 North America Spinal Devices and Biologics Market, Revenues & Volume, By Platelet Rich Plasma, 2021 - 2031 |
6.2.5 North America Spinal Devices and Biologics Market, Revenues & Volume, By Growth Factors, 2021 - 2031 |
6.3 North America Spinal Devices and Biologics Market, Revenues & Volume, By Surgery Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Spinal Devices and Biologics Market, Revenues & Volume, By Fusion Surgery, 2021 - 2031 |
6.3.3 North America Spinal Devices and Biologics Market, Revenues & Volume, By Minimally Invasive, 2021 - 2031 |
6.3.4 North America Spinal Devices and Biologics Market, Revenues & Volume, By Reconstructive Surgery, 2021 - 2031 |
6.3.5 North America Spinal Devices and Biologics Market, Revenues & Volume, By Fusion Procedures, 2021 - 2031 |
6.4 North America Spinal Devices and Biologics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America Spinal Devices and Biologics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Spinal Devices and Biologics Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 North America Spinal Devices and Biologics Market, Revenues & Volume, By Research Centers, 2020 - 2028 |
6.4.5 North America Spinal Devices and Biologics Market, Revenues & Volume, By Rehabilitation Centers, 2020 - 2028 |
6.5 North America Spinal Devices and Biologics Market, Revenues & Volume, By Product Form, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America Spinal Devices and Biologics Market, Revenues & Volume, By Injectable, 2020 - 2028 |
6.5.3 North America Spinal Devices and Biologics Market, Revenues & Volume, By Biocompatible Materials, 2020 - 2028 |
6.5.4 North America Spinal Devices and Biologics Market, Revenues & Volume, By Membranes, 2020 - 2028 |
6.5.5 North America Spinal Devices and Biologics Market, Revenues & Volume, By Gels, 2020 - 2028 |
7 North America Spinal Devices and Biologics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Spinal Devices and Biologics Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.2.1 United States (US) Spinal Devices and Biologics Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.2.2 Canada Spinal Devices and Biologics Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.2.3 Rest of North America Spinal Devices and Biologics Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.3 North America Spinal Devices and Biologics Market Revenues & Volume Share, By Biologics Type, 2021 & 2031F |
7.3.1 United States (US) Spinal Devices and Biologics Market, Revenues & Volume, By Biologics Type, 2021 - 2031 |
7.3.2 Canada Spinal Devices and Biologics Market, Revenues & Volume, By Biologics Type, 2021 - 2031 |
7.3.3 Rest of North America Spinal Devices and Biologics Market, Revenues & Volume, By Biologics Type, 2021 - 2031 |
7.4 North America Spinal Devices and Biologics Market, Revenues & Volume, By Surgery Type, 2021 - 2031 |
7.4.1 United States (US) Spinal Devices and Biologics Market, Revenues & Volume, By Surgery Type, 2021 - 2031 |
7.4.2 Canada Spinal Devices and Biologics Market, Revenues & Volume, By Surgery Type, 2021 - 2031 |
7.4.3 Rest of North America Spinal Devices and Biologics Market, Revenues & Volume, By Surgery Type, 2021 - 2031 |
7.5 North America Spinal Devices and Biologics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) Spinal Devices and Biologics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada Spinal Devices and Biologics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America Spinal Devices and Biologics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Spinal Devices and Biologics Market, Revenues & Volume, By Product Form, 2021 - 2031 |
7.6.1 United States (US) Spinal Devices and Biologics Market, Revenues & Volume, By Product Form, 2021 - 2031 |
7.6.2 Canada Spinal Devices and Biologics Market, Revenues & Volume, By Product Form, 2021 - 2031 |
7.6.3 Rest of North America Spinal Devices and Biologics Market, Revenues & Volume, By Product Form, 2021 - 2031 |
8 North America Spinal Devices and Biologics Market Key Performance Indicators |
9 North America Spinal Devices and Biologics Market - Export/Import By Countries Assessment |
10 North America Spinal Devices and Biologics Market - Opportunity Assessment |
10.1 North America Spinal Devices and Biologics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Spinal Devices and Biologics Market Opportunity Assessment, By Device Type, 2021 & 2031F |
10.3 North America Spinal Devices and Biologics Market Opportunity Assessment, By Biologics Type, 2021 & 2031F |
10.4 North America Spinal Devices and Biologics Market Opportunity Assessment, By Surgery Type, 2021 & 2031F |
10.5 North America Spinal Devices and Biologics Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 North America Spinal Devices and Biologics Market Opportunity Assessment, By Product Form, 2021 & 2031F |
11 North America Spinal Devices and Biologics Market - Competitive Landscape |
11.1 North America Spinal Devices and Biologics Market Revenue Share, By Companies, 2022 |
11.2 North America Spinal Devices and Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here